FDA Probes Child Death Linked to Drug for Blood Clotting Disorder

(MedPage Today) — The FDA said it has received postmarketing reports of neutralizing antibodies to ADAMTS13, including one death, in patients with congenital thrombotic thrombocytopenic purpura (cTTP) who were treated with the recombinant ADAMTS13…